坦索罗辛用于肛肠病术后尿潴留的疗效观察

Effect Observation on Tamsulosin in the Treatment of Postoperative Uroschesis of Coloproctological Disease Patients

为观察坦索罗辛用于肛肠病术后尿潴留的临床效果,将40例肛肠病术后患者随机分为对照组和观察组,每组20例。观察组患者于术前1d晚和术后4h口服坦索罗辛治疗,对照组以安慰剂治疗,比较2组患者术后尿潴留的发生率和术后首次排尿时间等情况。结果显示,观察组患者术后尿潴留的发生率为10%,对照组患者术后尿潴留的发生率为35%,2组比较差异有统计学意义(P <0.05);观察组患者术后首次排尿时间短于对照组(P <0.05)。结果表明,在肛肠外科术后预防性使用坦索罗辛可以有效降低术后尿潴留的发生率,缩短患者术后首次排尿时间,效果显著。

This study was to observe the clinical effect of tamsulosin in the treatment of postoperative uroschesis of patients with coloproctological disease,randomly divided 40 cases met above conditions into observation group(20 cases,orally administered tamsulosin on the night before surgery,as well at 4 hrs after surgery)and control group(20 cases,instead of placebo);then,compared both groups’ incidence of postoperative uroschesis,and status on first urination.As results,in the incidence of postoperative uroschesis,and in the time for first postoperative urination,observation group was respectively lower(10% vs35%),and shorter than control group(all,P <0.05).Results show that prophylactically administering tamsulosin after surgery can effectively reduce the incidence of uroschesis,shorten patients’ time for first urination,and these efficacy is significant.